PT1515714E - Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico - Google Patents
Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico Download PDFInfo
- Publication number
- PT1515714E PT1515714E PT03732804T PT03732804T PT1515714E PT 1515714 E PT1515714 E PT 1515714E PT 03732804 T PT03732804 T PT 03732804T PT 03732804 T PT03732804 T PT 03732804T PT 1515714 E PT1515714 E PT 1515714E
- Authority
- PT
- Portugal
- Prior art keywords
- cosmetic
- treatment
- therapeutical
- compounds
- nutraceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000002537 cosmetic Substances 0.000 title abstract 3
- 239000002417 nutraceutical Substances 0.000 title abstract 3
- 235000021436 nutraceutical agent Nutrition 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 125000000524 functional group Chemical group 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 230000037380 skin damage Effects 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000521A ITTO20020521A1 (it) | 2002-06-17 | 2002-06-17 | Procedimento per la preparazione di acidi policosanoici e policosanoli |
| ITTO20021049 ITTO20021049A1 (it) | 2002-12-03 | 2002-12-03 | Composti ossigenati insaturi a lunga catena e loro impiego in campo terapeutico, cosmetico e nutraceutico. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1515714E true PT1515714E (pt) | 2009-10-06 |
Family
ID=29738175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03732804T PT1515714E (pt) | 2002-06-17 | 2003-06-16 | Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7649103B2 (pt) |
| EP (1) | EP1515714B1 (pt) |
| CN (1) | CN1665495A (pt) |
| AT (1) | ATE439127T1 (pt) |
| AU (2) | AU2003240187A1 (pt) |
| DE (1) | DE60328785D1 (pt) |
| ES (1) | ES2329888T3 (pt) |
| PT (1) | PT1515714E (pt) |
| RU (1) | RU2331415C2 (pt) |
| WO (2) | WO2003106397A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070142657A1 (en) * | 2003-11-17 | 2007-06-21 | Georgios Sarakinos | Process for the preparation of aliphatic primary alcohols and intermediates in such process |
| WO2006042835A1 (en) * | 2004-10-18 | 2006-04-27 | Dsm Ip Assets B.V. | Process for the preparation of aliphatic primary alcohols and related intermediates in such process |
| WO2009133586A1 (ja) * | 2008-04-28 | 2009-11-05 | 有限会社アンティアンティ | アルツハイマー病の治療医薬 |
| WO2010103549A2 (en) * | 2009-03-12 | 2010-09-16 | Godavari Biorefineries Ltd | A method of obtaining policosanols from natural material |
| FR2950061B1 (fr) | 2009-09-11 | 2013-12-20 | Coatex Sas | Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations |
| CN102115425A (zh) * | 2009-12-30 | 2011-07-06 | 重庆华邦胜凯制药有限公司 | 一种直链烯醇及其制备方法 |
| US9296677B2 (en) * | 2010-10-01 | 2016-03-29 | Dsm Ip Assets B.V. | Synthesis of peretinoin |
| US20130296425A1 (en) * | 2011-01-31 | 2013-11-07 | Nagoya Industrial Science Research Institute | Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agents |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
| SU1537264A1 (ru) * | 1985-07-09 | 1990-01-23 | Томский Медицинский Институт | Способ коррекции иммунной недостаточности у детей с ожирением |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| CU22229A1 (es) * | 1992-09-29 | 1996-01-31 | Dalmer Lab Sa | Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la |
| RU2113853C1 (ru) * | 1995-11-24 | 1998-06-27 | Татьяна Всеволодовна Тимофеева | Препарат "курдлипид" |
| RU2063766C1 (ru) * | 1995-12-19 | 1996-07-20 | Индивидуальное частное предприятие "Лечебно-оздоровительный комплекс доктора Клюсса" | Способ оздоровления организма |
| EP1785492B1 (en) * | 1996-07-23 | 2010-05-26 | Nagase Chemtex Corporation | Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| CU22723A1 (es) * | 1997-04-02 | 2002-02-28 | Dalmer Lab Sa | Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos |
| GB9715444D0 (en) * | 1997-07-22 | 1997-09-24 | Scotia Holdings Plc | Therapeutic and dietary compositions |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| CA2340223A1 (en) * | 1998-08-12 | 2000-02-24 | Morinaga Milk Industry Co., Ltd. | Nutritional compositions for preventing or treating hyperlipoproteinemia |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| CA2290885A1 (fr) * | 1999-12-02 | 2001-06-02 | Universite De Sherbrooke | Methode pour la transformation des tissus du loup marin |
| EP1121928B1 (en) * | 2000-01-31 | 2008-01-23 | Härting S.A. | Compositions containing phytosterol and policosanol esters of fatty acids for reducing blood cholesterol and triglycerides |
| JP2002069111A (ja) * | 2000-06-13 | 2002-03-08 | Japan Science & Technology Corp | 重合分子鎖の作成方法 |
-
2003
- 2003-06-16 PT PT03732804T patent/PT1515714E/pt unknown
- 2003-06-16 CN CN038140519A patent/CN1665495A/zh active Pending
- 2003-06-16 AU AU2003240187A patent/AU2003240187A1/en not_active Abandoned
- 2003-06-16 AT AT03732804T patent/ATE439127T1/de not_active IP Right Cessation
- 2003-06-16 ES ES03732804T patent/ES2329888T3/es not_active Expired - Lifetime
- 2003-06-16 RU RU2005100847/04A patent/RU2331415C2/ru not_active IP Right Cessation
- 2003-06-16 DE DE60328785T patent/DE60328785D1/de not_active Expired - Lifetime
- 2003-06-16 AU AU2003240189A patent/AU2003240189A1/en not_active Abandoned
- 2003-06-16 WO PCT/IB2003/002311 patent/WO2003106397A1/en not_active Ceased
- 2003-06-16 EP EP03732804A patent/EP1515714B1/en not_active Expired - Lifetime
- 2003-06-16 US US10/518,091 patent/US7649103B2/en not_active Expired - Fee Related
- 2003-06-16 WO PCT/IB2003/002317 patent/WO2003105822A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003106397A1 (en) | 2003-12-24 |
| RU2005100847A (ru) | 2005-10-10 |
| US7649103B2 (en) | 2010-01-19 |
| EP1515714A1 (en) | 2005-03-23 |
| RU2331415C2 (ru) | 2008-08-20 |
| AU2003240187A1 (en) | 2003-12-31 |
| ES2329888T3 (es) | 2009-12-02 |
| DE60328785D1 (de) | 2009-09-24 |
| EP1515714B1 (en) | 2009-08-12 |
| US20050234127A1 (en) | 2005-10-20 |
| AU2003240189A1 (en) | 2003-12-31 |
| ATE439127T1 (de) | 2009-08-15 |
| WO2003105822A1 (en) | 2003-12-24 |
| CN1665495A (zh) | 2005-09-07 |
| WO2003105822A8 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Galanakis et al. | Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity | |
| UA109252C2 (uk) | Сірковмісні ліпіди для застосування як харчових добавок або медикаментів | |
| ES2094350T3 (es) | Cromano y tiocromanos con sustituyentes de feniletinilo en la posicion 7 que tienen actividad biologica de tipo retinoide. | |
| ES2102502T3 (es) | Esteres 7-cromanilicos de fenoles y acidos benzoicos que tienen actividad de tipo retinoide. | |
| DK0752855T3 (da) | Anvendelse af fedtsyreestere som bioadhæsive substanser | |
| RU2013145701A (ru) | Способ лечения нейротравмы | |
| WO2009091538A3 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
| WO2002018324A3 (en) | Immunoregulatory compounds, derivatives thereof and their use | |
| BRPI0413970A (pt) | composição de éster ramificado, composição para o cuidado pessoal, e, uso da composição de éster ramificado | |
| PT1515714E (pt) | Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico | |
| BR112014005546A2 (pt) | ácidos graxos ômega para tratamento de doenças | |
| EP2272383A1 (en) | Composition Comprising Omega-7 and/or Omega-4 Fatty Acids | |
| JP5587333B2 (ja) | 抗アクネ剤としての多価不飽和脂肪酸およびジオールエステル | |
| EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
| AU2016219617A1 (en) | Positively charged water-soluble prodrugs of aspirin | |
| KR870700065A (ko) | 신규한 카본산 에스테르 | |
| RU2742769C2 (ru) | Амидопроизводные поликофеоилхинных кислот, способ их получения и их применения | |
| RU2011127082A (ru) | Косметические и фармацевтические композиции молекул каликсарена | |
| RU2008138380A (ru) | Использование dha и ara для получения композиции, предназначенной для регуляции экспрессии генов | |
| RU2009102271A (ru) | Производные фенилуксусной кислоты как ингибиторы цог-2(циклооксигеназы-2) | |
| ATE341331T1 (de) | Lipide zur änderung des abwehrsystems | |
| RU2011152276A (ru) | Моноэфиры и диэфиры аскорбиновой кислоты с ненасыщенными жирными кислотами и их косметическое применение | |
| WO2008131863A3 (de) | Ester von hexyldecanol mit kurzkettigen fettsäuren | |
| DE502004004660D1 (de) | Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff | |
| DE60024326D1 (de) | Lipide zur stimulierung der immunreaktion |